Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
ASX:MYX
Price:
5.74 AUD
-9.89%
Market Closed
Updated:
May 20, 2024
Mayne Pharma Group Ltd
Other Receivables
|
Mayne Pharma Group Ltd
Other Receivables Peer Comparison
Comparables:
RCE
NEU
BOT
PBP
C
CU6
Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Other Receivables
AU$32.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Other Receivables
AU$176.6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Other Receivables
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Other Receivables
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Probiotec Ltd
ASX:PBP
|
Other Receivables
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Other Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayne Pharma Group Ltd's Other Receivables?
Other Receivables
32.1m
AUD
32.1m
AUD
Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Other Receivables amounts to 32.1m AUD.
What is Mayne Pharma Group Ltd's Other Receivables growth rate?
Other Receivables CAGR 5Y
7%
7%
Over the last year, the Other Receivables growth was 38%. The average annual Other Receivables growth rates for Mayne Pharma Group Ltd have been -8% over the past three years , 7% over the past five years .
You don't have any saved screeners yet
